4 insiders buy $6.7 mil of Small-Cap – Week of 12/10

Investors should always be on the lookout for insights that could give them an edge in the stock market, and one potential source of such information is insider buying activity. When company insiders, such as executives or board members, buy shares of a company’s stock, it can be seen as a vote of confidence in the company’s prospects. Publicly available insider buying information can provide valuable clues about which stocks may be worth considering for investment.

Here are three stocks recently purchased by C-level insiders –

RXO, Inc. – SYM: RXO
Recent Price: $23.04
Insider Action: 4 insiders buy $6.7 mil in shares
Description: RXO, Inc. provides full truckload freight transportation brokering services. The company also offers brokered services for managed transportation, last mile, and freight forwarding. RXO, Inc. was founded in 2022 and is based in Charlotte, North Carolina.

Do You Hold an IRA, Roth IRA, 401(k) or Pension?

Brace yourself… because your retirement money is now at serious risk. It all has to do with a new law on the books that’s designed to eat away at Americans’ retirement funds – quietly and efficiently.

To learn what’s at stake, click here for retirement expert Bob Carlson’s new video – along with his #1 strategy for keeping your nest egg where it belongs… with YOU.


CARGO Therapeutics, Inc. – SYM: CRGX
Recent Price: $16.28
Insider Action: 3 insiders buy $39 mil in shares
Description: CARGO Therapeutics, Inc., a clinical-stage biotechnology company, develops chimeric antigen receptor (CAR) T-cell therapies for cancer patients. The company’s lead program is CRG-022, an autologous CD22 CAR T-cell product candidate designed to address resistance mechanisms by targeting CD22, an alternate tumor antigen that is expressed in B-cell malignancies. It also develops CRG-023, a tri-specific CAR T product candidate that targets tumor cells with three B-cell antigen targets. The company was formerly known as Syncopation Life Sciences, Inc. and changed its name to CARGO Therapeutics, Inc. in September 2022. CARGO Therapeutics, Inc. was incorporated in 2019 and is headquartered in San Mateo, California.

Top 5 “Portfolio Supercharging” Stocks – Free Report from Zacks Investment Research

Zacks has a proven track record for picking big winners. And now, our team of experts has hand-selected, from thousands of companies, the 5 stocks they predict they have outsized gain-potential NOW and in the coming year. Recent recommendations have climbed as high as +288%. In fact, the newest report could point to even bigger gains. These picks will surprise you and current market conditions could make our new recommendations even more profitable. This special arrangement is good for a limited time only.

Take a look and act now!


RumbleON, Inc. – SYM: RMBL
Recent Price: $6.66
Insider Action: 3 insiders buy $18 mil in shares
Description: RumbleON, Inc. operates a technology-based omnichannel platform in North America. It operates through three segments: Powersports, Automotive, and Vehicle Logistics. The Powersports segment distributes motorcycles and other powersports vehicles. The Automotive segment distributes cars and trucks. The Vehicle Logistics segment provides nationwide transportation brokerage services between dealerships and auctions. Its platform offers ability to buy, sell, trade, and finance new and pre-owned vehicles online or in store for dealers and consumers. The company was formerly known as Smart Server, Inc. and changed its name to RumbleON, Inc. in February 2017. RumbleON, Inc. was incorporated in 2013 and is based in Irving, Texas.

deal of the month

best growth stocks


Bundle package – lifetime subscriptions for all products


Recent posts


Connect with Us

Get FREE Daily Stock Tips

Join and receive market insider stock picks, trade alerts and unique investing insights
This field is for validation purposes and should be left unchanged.
By clicking the "Subscribe" button you are accepting our Terms of Use and Privacy Policy.

Join Waitlist

We’re sorry, but due to the popularity of our services, we have reached our max number of subscribers and are not currently accepting more. If spots become available, we will be sure to contact you. Please join the waitlist below.
Thank You!

"*" indicates required fields

This field is for validation purposes and should be left unchanged.